---
title: "CAPR Capricor Therapeutics"
author: "Akshay Gulabrao"
date : "2025 October 27"
bibliography: library.bib
link-citations: true
---

[Home](./index.html)

---

Capricor Therapeutics (CAPR) has a drug named Deramiocel (CAP-1002) to treat Duchenne muscular dystrophy. It's currently in Phase 3 and they are due to release data in a few weeks.

Martin doesn't think the drug works.

Duchenne Muscular Dystrophy is a severe X-linked recessive disorder caused by mutations in the DMD gene, which encodes a structural cytoskeletal protein in muscle cells named **dystrophin**. 

![[OpenStax Anatomy](https://openstax.org/books/anatomy-and-physiology-2e/pages/10-2-skeletal-muscle)](./media/skeletal-muscle-hierarchy.png)

![https://openstax.org/books/anatomy-and-physiology-2e/pages/10-2-skeletal-muscle](./media/sarcomere.png)
